`
Thursday, 20 July 2017

Pharma News

  • USFDA approval for Alembic Pharma

    Pharma |  News | By Srinivas Rasoor | 0 Comment | 10 Apr, 2017

    The US Food and Drug Administration has given approval to Alembic Pharmaceuticals for generic Fluoxetine Hydrochloride tablets used for the treatment of depression and panic disorder. This ...Read more

  • Japan's Astellas pharma to acquire Belgium firm Ogeda

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 07 Apr, 2017

    Singapore: If reports are to be believed, Japan's Astellas pharma is all set to acquire Belgium's clinical-stage drug discovery firm Ogeda for around €800m. Ogeda is engaged in the di...Read more

  • USFDA approval for Glenmark's skin ointment

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 23 Mar, 2017

    The United States Food and Drug Administration (USFDA) has given its nod for Clobetasol Propionate Ointment, used for the treatment of various skin conditions. The product has been manufact...Read more

  • Novartis heart-failure med Entresto cuts A1c

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2017

    Novartis announced results of a new post-hoc analysis in a subgroup of patients with reduced ejection fraction heart failure (HFrEF) and diabetes suggesting that Entresto (sacubitril/valsar...Read more

  • Takeda off-loads some drug development to JV

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2017

    Singapore: In a bid to concentrate resources on the core focus areas, Japanese drug giant Takeda Pharmaceutical has formed a 10 billion yen ($87.2 million) drug development company with two...Read more

  • Cipla agrees to divest its animal health business in South Africa and Sub-Saharan Africa

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2017

    Cipla Ltd, a global pharmaceutical company announced that it has entered into agreements, through its Wholly Owned Subsidiary Inyanga Trading 386 Proprietary Limited, with the group compan...Read more

  • TA Associates announces investment in Ideal Cures

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2017

    TA Associates, a leading global growth private equity firm, today announced it has completed an investment in Ideal Cures Private Limited, a supplier of ready-to-use coating products and ex...Read more

  • Novo Nordisk appoints new executive vice president

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2017

    Novo Nordisk has announced Jakob Riis as its new executive vice president, head of North America Operations after the resignation of the president of Novo Nordisk Inc. from the company. Ja...Read more

  • USFDA warning on Indian drugs

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2017

    The US Food and Drug Administration (FDA) wants Indian drug manufacturers to get their act together, citing instances of sale of drugs which lack the stated content and complaints of medici...Read more

  • China updates list of key reimbursable medicines

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 23 Feb, 2017

    Singapore: The Chinese Ministry of Human Resources and Social Security recently announced the updation of key list of medicines covered by basic medical insurance schemes. Inclusion on the ...Read more

  • Lupin inks pact to distribute antidepressant drug in Japan

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2017

    Singapore: India based drug giant Lupin pharmaceuticals Japanese subsidiary Kyowa recently inked a pact with Japan's Astellas pharma seeking exclusive rights to distribute and promote exten...Read more

  • VIVO Healthcare received investment from ICCO of Netherlands

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2017

    VIVO Healthcare  announced that it has received a strategic investment from ICCO Investments, the investment arm of Netherlands based ICCO Cooperation. Founded by Shakti Singh and Reena Pu...Read more

  • Mundipharma expands oncology portfolio

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 16 Feb, 2017

    Singapore: Mundipharma and Helsinn Group have expanded their collaboration, signing amendments to licensing and distribution agreements for anti-emetic prophylactic agents ALOXI and AKYNZEO...Read more

  • Pfizer announces closure of its Australian facility

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 16 Feb, 2017

    Singapore: Global pharma giant Pfizer recently announced its plans to close an Australian manufacturing plant by 2021 that produces, an intermediate of a biosimilar to Amgen's Neulasta (peg...Read more

  • Daiichi Sankyo closes its Japanese research subsidiary

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 13 Feb, 2017

    Singapore: Daiichi Sankyo recently announced its plans to close its Japanese research subsidiary Asubio Pharma that focuses research primarily on psychiatric and neurological diseases, immu...Read more

  • FDA approves first treatment for rare form of skin cancer

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 25 Mar, 2017

    The U.S. Food and Drug Administration granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell c...Read more

  • South Korea approves commercialization of Zestra

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2017

    Singapore: San Diego Based Innovus Pharmaceuticals has announced that its partner J&H Co. LTD, a South Korean company ("J&H"), received approval to commercialize Zestra from the Kor...Read more

  • Japanese pharmaceuticals collaborate on dementia treatment

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 02 Feb, 2017

    Takeda Pharmaceutical and Shionogi & Co. along with other three Japanese drug companies recently collaborated to develop treatment techniques for dementia and similar neurological disea...Read more

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls